BiotechTubeBiotechTube
Home/Cabaletta Bio/Scott Brun
SB

Scott Brun

Independent Director

Cabaletta Bio

Therapeutic Areas

Autoimmune DiseasesRheumatologyDermatologyNeurology

Cabaletta Bio Pipeline

DrugIndicationPhase
rese-cel (resecabtagene autoleucel)Systemic Lupus Erythematosus (SLE)Phase 1/2

Leadership Team at Cabaletta Bio

SN
Steven Nichtberger
President, Chief Executive Officer, and Co-Founder
SB
Samik Basu
Chief Scientific Officer
GB
Gwendolyn Binder
President, Science & Technology
CB
Catherine Bollard
Independent Director
AP
Aimee Payne
Scientific Advisory Board Member
MC
Michael C. Milone
Scientific Advisory Board Member
JS
Jay Siegel
Scientific Advisory Board Member
View full Cabaletta Bio profile